相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study
Sudha Sundar et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
Decellularized normal and cancer tissues as tools for cancer research
E. Gentilin et al.
CANCER GENE THERAPY (2022)
A source of hope for platinum-resistant ovarian cancer?
Sarah P Blagden et al.
LANCET (2021)
Ex vivo culture of intact human patient derived pancreatic tumour tissue
John Kokkinos et al.
SCIENTIFIC REPORTS (2021)
Organoid and Spheroid Tumor Models: Techniques and Applications
Sreenivasulu Gunti et al.
CANCERS (2021)
Engineering a Vascularized 3D Hybrid System to Model Tumor-Stroma Interactions in Breast Cancer
Filipa C. Teixeira et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
New Predictive Biomarkers for Ovarian Cancer
Ghofraan Abdulsalam Atallah et al.
DIAGNOSTICS (2021)
Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays
Larissa Bueno Tofani et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Elizabeth M. Swisher et al.
NATURE COMMUNICATIONS (2021)
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery
Christina Fotopoulou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2021)
Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging
Vessela Vassileva et al.
BIOMEDICINES (2021)
A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasion
Beatrice Malacrida et al.
ISCIENCE (2021)
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer
Shuang Zhang et al.
CANCER DISCOVERY (2021)
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Changxin Wan et al.
CANCER RESEARCH (2021)
Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis
Hilary A. Kenny et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
Ian R. Powley et al.
BRITISH JOURNAL OF CANCER (2020)
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment
Karen Hoffmann et al.
EMBO JOURNAL (2020)
Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update
Christina Fotopoulou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma
Hui Chen et al.
GYNECOLOGIC ONCOLOGY (2020)
Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids
Kadi Lohmussaar et al.
NATURE COMMUNICATIONS (2020)
Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
Nina Maenhoudt et al.
STEM CELL REPORTS (2020)
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
Justin W. Gorski et al.
DIAGNOSTICS (2020)
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
Katrin Kleinmanns et al.
EBIOMEDICINE (2020)
Applying Tissue Slice Culture in Cancer Research-Insights from Preclinical Proton Radiotherapy
Theresa Suckert et al.
CANCERS (2020)
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
Yoshiko Nanki et al.
SCIENTIFIC REPORTS (2020)
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses
Chris Jenske de Witte et al.
CELL REPORTS (2020)
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
María Ochoa de Olza et al.
LANCET ONCOLOGY (2020)
Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer
Clara Louise Hedegaard et al.
SCIENCE ADVANCES (2020)
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
Lise M. van Wijk et al.
CANCERS (2020)
Microtechnology-based methods for organoid models
Vanessa Velasco et al.
MICROSYSTEMS & NANOENGINEERING (2020)
A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapies
Neda Dadgar et al.
MICROSYSTEMS & NANOENGINEERING (2020)
Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures
Sofia Abreu et al.
SCIENTIFIC REPORTS (2020)
Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells
Huizhen Sun et al.
THERANOSTICS (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Tumour heterogeneity and the evolutionary trade-offs of cancer
Jean Hausser et al.
NATURE REVIEWS CANCER (2020)
A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions
Danh Truong et al.
BIOMATERIALS (2019)
PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
Xuan Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
A Photo-Crosslinkable Kidney ECM-Derived Bioink Accelerates Renal Tissue Formation
Mohamed Ali et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
U. A. Matulonis et al.
ANNALS OF ONCOLOGY (2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N. Colombo et al.
ANNALS OF ONCOLOGY (2019)
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer
Caroline Kreuzinger et al.
CANCER LETTERS (2019)
Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors
Yoshiaki Maru et al.
GYNECOLOGIC ONCOLOGY (2019)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Oded Kopper et al.
NATURE MEDICINE (2019)
Current Status of Patient-Derived Ovarian Cancer Models
Yoshiaki Maru et al.
CELLS (2019)
Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome
Marcia Hall et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Xenograft and organoid model systems in cancer research
Margit Bleijs et al.
EMBO JOURNAL (2019)
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S. Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
Dohyun Park et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer Cell Lines Are Useful Model Systems for Medical Research
Peppino Mirabelli et al.
CANCERS (2019)
Patient-Derived Xenograft Models of Breast Cancer and Their Application
Takahiko Murayama et al.
CELLS (2019)
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
Alexander Reuss et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Immunotherapy in Ovarian Cancer: Are We There Yet?
Lana E. Kandalaft et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
A. Gonzalez-Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
Shuang Zhang et al.
NATURE COMMUNICATIONS (2019)
The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors
Grissel Trujillo-de Santiago et al.
MATERIALS (2019)
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
Ramya Sivakumar et al.
ONCOIMMUNOLOGY (2019)
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Giovanna Damia et al.
CANCERS (2019)
Spheroid Culture System Methods and Applications for Mesenchymal Stem Cells
Na-Eun Ryu et al.
CELLS (2019)
In Vitro Research Reproducibility: Keeping Up High Standards
Cordula Hirsch et al.
FRONTIERS IN PHARMACOLOGY (2019)
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Nhan Phan et al.
COMMUNICATIONS BIOLOGY (2019)
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
M. R. Mirza et al.
ANNALS OF ONCOLOGY (2018)
Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling
Yingxia Ning et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics
Carmela Ricciardelli et al.
CANCER LETTERS (2018)
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research
Martina Piccoli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy
Sanghamitra Mylavarapu et al.
FRONTIERS IN ONCOLOGY (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
The Role of Desmoplasia and Stromal Fibroblasts on Anti-cancer Drug Resistance in a Microengineered Tumor Model
Harpinder Saini et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2018)
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J. Hill et al.
CANCER DISCOVERY (2018)
Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment
Karen M. Watters et al.
CANCERS (2018)
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal et al.
CELL (2018)
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
Renata Rodrigues da Cunha Colombo Bonadio et al.
CLINICS (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
Hanxiao Xu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
Titia G. Meijer et al.
CLINICAL CANCER RESEARCH (2018)
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
Joyce F. Liu et al.
CLINICAL CANCER RESEARCH (2017)
Targeting DNA repair and replication stress in the treatment of ovarian cancer
Junko Murai
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective
Christina Fotopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A novel 3-D bio-microfluidic system mimicking in vivo heterogeneous tumour microstructures reveals complex tumour-stroma interactions
Qihui Fan et al.
LAB ON A CHIP (2017)
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman et al.
LANCET (2017)
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations
Julia Jabs et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
Functional characterisation of a novel ovarian cancer cell line, NUOC-1
Aiste McCormick et al.
ONCOTARGET (2017)
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
Shan-Shan Li et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
Katherine M. Morgan et al.
FRONTIERS IN ONCOLOGY (2017)
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
Madhu Lal-Nag et al.
SLAS DISCOVERY (2017)
Three-Dimensional Cell Cultures in Drug Discovery and Development
Ye Fang et al.
SLAS DISCOVERY (2017)
Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2
Nilesh Brijwani et al.
SCIENTIFIC REPORTS (2017)
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells
Stefania Parlato et al.
SCIENTIFIC REPORTS (2017)
The Impact of Microenvironment on the Synovial Sarcoma Transcriptome
Huifeng Jin et al.
CANCER MICROENVIRONMENT (2017)
Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
Shreya Raghavan et al.
CLINICAL CANCER RESEARCH (2017)
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
Titia G. Meijer et al.
FUTURE SCIENCE OA (2017)
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
Jun Li et al.
CANCER CELL (2017)
Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity
Tatsuya Ishiguro et al.
CANCER RESEARCH (2016)
3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments
Anna V. Taubenberger et al.
ACTA BIOMATERIALIA (2016)
A three dimensional micropatterned tumor model for breast cancer cell migration studies
Nitish Peela et al.
BIOMATERIALS (2016)
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
Denis Querleu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform
P. Sabhachandani et al.
LAB ON A CHIP (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Yves Pommier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Patient-derived xenograft (PDX) tumors increase growth rate with time
Alexander T. Pearson et al.
ONCOTARGET (2016)
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
Carman K. M. Ip et al.
SCIENTIFIC REPORTS (2016)
Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening
Yongli Chen et al.
ANALYTICA CHIMICA ACTA (2015)
A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance
Raphael Ceccaldi et al.
CANCER RESEARCH (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro
Sun-Ah Kim et al.
EXPERIMENTAL CELL RESEARCH (2015)
Role of aggressive surgical cytoreduction in advanced ovarian cancer
Suk-Joon Chang et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza et al.
LANCET ONCOLOGY (2015)
REV7 counteracts DNA double-strand break resection and affects PARP inhibition
Guotai Xu et al.
NATURE (2015)
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
A. K. Mitra et al.
ONCOGENE (2015)
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy
Hilary A. Kenny et al.
NATURE COMMUNICATIONS (2015)
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
Biswanath Majumder et al.
NATURE COMMUNICATIONS (2015)
The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids
Mirjana Kessler et al.
NATURE COMMUNICATIONS (2015)
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
CANCER DISCOVERY (2015)
Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices
Emma Davies et al.
SCIENTIFIC REPORTS (2015)
A comprehensive transcriptional portrait of human cancer cell lines
Christiaan Klijn et al.
NATURE BIOTECHNOLOGY (2015)
Tumorigenesis: it takes a village
Doris P. Tabassum et al.
NATURE REVIEWS CANCER (2015)
Digital Microfluidics for Automated Hanging Drop Cell Spheroid Culture
Andrew P. Aijian et al.
JALA (2015)
Gelatine methacrylamide-based hydrogels: An alternative three-dimensional cancer cell culture system
Elke Kaemmerer et al.
ACTA BIOMATERIALIA (2014)
Advances in patient-derived tumor xenografts: From target identification to predicting clinical response rates in oncology
Edward Rosfjord et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments
Lina W. Dunne et al.
BIOMATERIALS (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Chromosomal Instability and Telomere Shortening in Long-Term Culture of Hematopoietic Stem Cells: Insights from a Cell Culture Model of RPS14 Haploinsufficiency
K. Thomay et al.
CYTOGENETIC AND GENOME RESEARCH (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Platinum resistant ovarian cancer: What is it, who to treat and how to measure benefit?
Alison Davis et al.
GYNECOLOGIC ONCOLOGY (2014)
Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate
Sophia Lisette Maund et al.
LABORATORY INVESTIGATION (2014)
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A microfluidic chip with a U-shaped microstructure array for multicellular spheroid formation, culturing and analysis
Chien-Yu Fu et al.
BIOFABRICATION (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experiment alsystems
Paula Cunnea et al.
FRONTIERS IN ONCOLOGY (2014)
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor
Louise J. Barber et al.
JOURNAL OF PATHOLOGY (2013)
Mechanisms of resistance to therapies targeting BRCA-mutant cancers
Christopher J. Lord et al.
NATURE MEDICINE (2013)
Ex vivo culture of human prostate tissue and drug development
Margaret M. Centenera et al.
NATURE REVIEWS UROLOGY (2013)
A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity
Stephen J. Pettitt et al.
PLOS ONE (2013)
Fluid-Flow Induced Wall Shear Stress and Epithelial Ovarian Cancer Peritoneal Spreading
Liron Avraham-Chakim et al.
PLOS ONE (2013)
Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
Michael S. Anglesio et al.
PLOS ONE (2013)
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
Imran Rizvi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors
Janneke E. Jaspers et al.
CANCER DISCOVERY (2013)
Human Lung Cancer Cells Grown on Acellular Rat Lung Matrix Create Perfusable Tumor Nodules
Dhruva K. Mishra et al.
ANNALS OF THORACIC SURGERY (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors
Jeffry L. Dean et al.
CELL CYCLE (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5
Daniel Herr et al.
GYNECOLOGIC ONCOLOGY (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma
Xiumei Zhao et al.
NEURO-ONCOLOGY (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Analysis of MDM2 and MDM4 Single Nucleotide Polymorphisms, mRNA Splicing and Protein Expression in Retinoblastoma
Justina McEvoy et al.
PLOS ONE (2012)
First-Line Therapy in Ovarian Cancer Trials
Tate Thigpen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
Barbara Norquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
Bradley J. Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
Ovarian Cancer
Kathleen R. Cho et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
MMP-2 functions as an early response protein in ovarian cancer metastasis
Hilary A. Kenny et al.
CELL CYCLE (2009)
Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Kristy Shield et al.
GYNECOLOGIC ONCOLOGY (2009)
Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs
Nirmala Parajuli et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2009)
Histologic subtypes of ovarian carcinoma: An overview
Robert A. Soslow
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum
Hilary A. Kenny et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI)
R Sandberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
AN Gordon et al.
GYNECOLOGIC ONCOLOGY (2004)
Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma
WT Huinink et al.
ANNALS OF ONCOLOGY (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
SS Bacus et al.
ONCOGENE (2001)
分享论文
